RNAi-mediated knockdown of PRL-3 inhibits cell invasion and downregulates ERK 1/2 expression in the human gastric cancer cell line, SGC-7901

Molecular Medicine Reports

Volumn 7, Issue 6, 2013, Pages 1805-1811

  Cao, Yi ^a   Tu, Yi ^a   Mei, Jinhong ^a   Li, Zhengrong ^a   Jie, Zhigang ^a   Xu, Shan ^a   Xu, Linlin ^a   Wang, Shanshan ^a   Xiong, Yifeng ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

ERK 1 2; Gastric carcinoma; Invasion and migration; PRL 3

Indexed keywords

MATRILYSIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHATASE OF REGENERATING LIVER 3 PROTEIN; SMALL INTERFERING RNA; TUMOR MARKER; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG POTENCY; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; RNA INTERFERENCE; STOMACH CANCER;

CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 7; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEOPLASM PROTEINS; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASES; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 84877303025     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1420     Document Type: Article

References (37)

1. Compare D, Rocco A and Nardone G: Risk factors in gastric cancer. Eur Rev Med Pharmacol Sci 14: 302-308, 2010.
2. Parkin DM, Bray F, Ferlay J and Pisani P: Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108, 2005.
3. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I, Iliopoulos D, Pilozzi E, Liu CG, Negrini M, et al: E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 13: 272-286, 2008.
4. Bessette DC, Qiu D and Pallen CJ: PRL PTPs: mediators and markers of cancer progression. Cancer Metastasis Rev 27: 231-252, 2008.
5. Andersen JN, Jansen PG, Echwald SM, Mortensen OH, Fukada T, Del Vecchio R, Tonks NK and Møller NP: A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage. Faseb J 18: 8-30, 2004.
6. Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J and Mustelin T: Protein tyrosine phosphatases in the human genome. Cell 117: 699-711, 2004.
7. Wu X, Zeng H, Zhang X, Zhao Y, Sha H, Ge X, Zhang M, Gao X and Xu Q: Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells. Am J Pathol 164: 2039-2054, 2004.
8. Stephens B, Han H, Hostetter G, Demeure MJ and Von Hoff DD: Small interfering RNA-mediated knockdown of PRL phosphatases results in altered Akt phosphorylation and reduced clonogenicity of pancreatic cancer cells. Mol Cancer Ther 7: 202-210, 2008.
9. Zeng Q, Dong JM, Guo K, Li J, Tan HX, Koh V, Pallen CJ, Manser E and Hong W: PRL-3 and PRL-1 promote cell migration, invasion, and metastasis. Cancer Res 63: 2716-2722, 2003.
10. Radke I, Götte M, Kersting C, Mattsson B, Kiesel L and Wülfing P: Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer. Br J Cancer 95: 347-354, 2006.
11. Zhou J, Wang S, Lu J, Li J and Ding Y: Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma. Int J Cancer 124: 1879-1886, 2009.
12. Li ZR, Wang Z, Zhu BH, He YL, Peng JS, Cai SR, Ma JP and Zhan WH: Association of tyrosine PRL-3 phosphatase protein expression with peritoneal metastasis of gastric carcinoma and prognosis. Surg Today 37: 646-651, 2007.
13. Sharma GD, He J and Bazan HE: p38 and ERK 1/2 coordinate cellular migration and proliferation in epithelial wound healing: evidence of cross-talk activation between MAP kinase cascades. J Biol Chem 278: 21989-21997, 2003.
14. Mu H, Wang X, Wang H, Lin P, Yao Q and Chen C: Lactosylceramide promotes cell migration and proliferation through activation of ERK1/2 in human aortic smooth muscle cells. Am J Physiol Heart Circ Physiol 297: H400-H408, 2009.
15. McCawley LJ, Li S, Wattenberg EV and Hudson LG: Sustained activation of the mitogen-activated protein kinase pathway. A mechanism underlying receptor tyrosine kinase specificity for matrix metalloproteinase-9 induction and cell migration. J Biol Chem 274: 4347-4353, 1999.
16. Deryugina EI and Quigley JP: Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25: 9-34, 2006.
17. Björklund M and Koivunen E: Gelatinase-mediated migration and invasion of cancer cells. Biochim Biophys Acta 1755: 37-69, 2005.
18. Luo Y, Liang F and Zhang ZY: PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1/2 pathways. Biochemistry 48: 1838-1846, 2009.
19. Zeng Q, Si X, Horstmann H, Xu Y, Hong W and Pallen CJ: Prenylation-dependent association of protein-tyrosine phosphatases PRL-1,-2, and-3 with the plasma membrane and the early endosome. J Biol Chem 275: 21444-21452, 2000.
20. Kato H, Semba S, Miskad UA, Seo Y, Kasuga M and Yokozaki H: High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases. Clin Cancer Res 10: 7318-7328, 2004.
21. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J, Wainscoat JS, et al: Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 141: 672-675, 2008.
22. Chambers AF, Groom AC and MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2: 563-572, 2002.
23. Weiss L: Metastasis of cancer: a conceptual history from antiquity to the 1990s. Cancer Metastasis Rev 19: 193-383, 2000.
24. Sun P, Yu H, Zhang WQ, Hu M and Lv R: Lentivirus-mediated siRNA targeting VEGF inhibits gastric cancer growth in vivo. Oncol Rep 28: 1687-1692, 2012.
25. Qin XJ, Dai DJ, Gao ZG, Huan JL and Zhu L: Effect of lentivirus-mediated shRNA targeting VEGFR-3 on proliferation, apoptosis and invasion of gastric cancer cells. Int J Mol Med 28: 761-768, 2011.
26. Dai N, Lu AP, Shou CC and Li JY: Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer. World J Gastroenterol 15: 1499-1505, 2009.
27. Wang Z, Cai SR, He YL, Zhan WH, Chen CQ, Cui J, Wu WH, Wu H, Song W, Zhang CH, et al: High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients. Ann Surg Oncol 16: 208-219, 2009.
28. Miskad UA, Semba S, Kato H, Matsukawa Y, Kodama Y, Mizuuchi E, Maeda N, Yanagihara K and Yokozaki H: High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study. Virchows Arch 450: 303-310, 2007.
29. Ming J, Liu N, Jiang GC, Zhang QF, Qiu XS and Wang EH: Downregulating PRL-3 inhibit migration and invasion of lung cancer cell via RhoA and mDia1. Tumori 98: 370-376, 2012.
30. Mizuuchi E, Semba S, Kodama Y and Yokozaki H: Down-modulation of keratin 8 phosphorylation levels by PRL-3 contributes to colorectal carcinoma progression. Int J Cancer 124: 1802-1810, 2009.
31. Peng L, Jin G, Wang L, Guo J, Meng L and Shou C: Identification of integrin alpha1 as an interacting protein of protein tyrosine phosphatase PRL-3. Biochem Biophys Res Commun 342: 179-183, 2006.
32. Kwak DH, Lee JH, Kim T, Ahn HS, Cho WK, Ha H, Hwang YH and Ma JY: Aristolochia manshuriensis Kom inhibits adipocyte differentiation by regulation of ERK 1/2 and Akt pathway. PLoS One 7: e49530, 2012.
33. Ma L, Lan F, Zheng Z, Xie F, Wang L, Liu W, Han J, Zheng F, Xie Y and Huang Q: Epidermal growth factor (EGF) and interleukin (IL)-1β synergistically promote ERK1/2-mediated invasive breast ductal cancer cell migration and invasion. Mol Cancer 11: 79, 2012.
34. Yang Y, Shi H, Li X and Yi Y: Effects of shRNA targeting maspin on invasion of gastric carcinoma SGC7901 cell line. Oncol Rep 25: 259-265, 2011.
35. Koskensalo S, Mrena J, Wiksten JP, Nordling S, Kokkola A, Hagström J and Haglund C: MMP-7 overexpression is an independent prognostic marker in gastric cancer. Tumour Biol 31: 149-155, 2010.
36. Zeng Q, Hong W and Tan YH: Mouse PRL-2 and PRL-3, two potentially prenylated protein tyrosine phosphatases homologous to PRL-1. Biochem Biophys Res Commun 244: 421-427, 1998.
37. Cates CA, Michael RL, Stayrook KR, Harvey KA, Burke YD, Randall SK, Crowell PL and Crowell DN: Prenylation of oncogenic human PTP (CAAX) protein tyrosine phosphatases. Cancer Lett 110: 49-55, 1996.